biguanides has been researched along with propranolol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Permutt, MA | 1 |
| Burke, GH; Calaresu, FR | 1 |
| Luk'ianchikov, VS | 1 |
| Fernández, MM; Martín, ML; Morán, A; San Román, L | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
1 review(s) available for biguanides and propranolol
| Article | Year |
|---|---|
Postprandiol hypoglycemia.
Topics: Administration, Oral; Adult; Biguanides; Blood Glucose; Diabetes Mellitus; Diet Therapy; Eating; Evaluation Studies as Topic; Fasting; Female; Glucose Tolerance Test; Humans; Hypoglycemia; Male; Phenytoin; Propranolol; Psychotherapy; Sulfonylurea Compounds; Surgical Procedures, Operative | 1976 |
4 other study(ies) available for biguanides and propranolol
| Article | Year |
|---|---|
An experimental analysis of the tachycardia that follows vagal stimulation.
Topics: Animals; Aorta; Atrial Function; Atropine; Biguanides; Cats; Cell Membrane Permeability; Cordotomy; Electric Stimulation; Heart; Heart Rate; Propranolol; Rabbits; Sinoatrial Node; Sodium; Spinal Cord; Vagus Nerve | 1972 |
[Diagnosis and treatment of hypoglycemia syndrome].
Topics: Biguanides; Blood Glucose; Diagnosis, Differential; Diet; Glucose Tolerance Test; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulinoma; Pancreatic Neoplasms; Propranolol; Radioimmunoassay | 1982 |
Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Topics: Amphetamines; Animals; Biguanides; Dose-Response Relationship, Drug; Enalapril; Indoles; Indomethacin; Male; Mesenteric Arteries; Mesentery; Perfusion; Piperazines; Prazosin; Propranolol; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Splanchnic Circulation; Vasoconstriction | 2000 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |